Hydroxypropyl Methyl Cellulose Acetate Succinate: Advanced Enteric Coating Solution
Discover the premium enteric coating capabilities of HPMCAS for your pharmaceutical formulations.
Get a Quote & SampleProduct Core Value
Hydroxypropyl Methyl Cellulose Acetate Succinate
This versatile pharmaceutical excipient, identified by CAS 71138-97-1, is a white to light yellow powder or granule that is odorless and tasteless. It is primarily utilized as an enteric coating material, providing essential protection for pharmaceutical preparations. Its applications extend to being a polymer carrier, a component in microcapsules, and microspheres, crucial for developing advanced drug delivery systems like sustained-release or controlled-release formulations.
- Explore the benefits of using HPMCAS for sustained release applications, ensuring targeted drug delivery.
- Understand how this enteric coating material can enhance the stability of sensitive pharmaceuticals.
- Learn about the specific properties of CAS 71138-97-1 that make it ideal for microencapsulation.
- Discover how this key pharmaceutical excipient supports advanced drug formulation strategies.
Key Advantages
Targeted Drug Delivery
Leverage HPMCAS for excellent enteric coating, ensuring your drug is released precisely where it's needed in the digestive tract, a crucial aspect of pharmaceutical enteric coating.
Enhanced Formulation Stability
Utilize the stable properties of HPMCAS to protect sensitive active pharmaceutical ingredients (APIs) from degradation, a common challenge addressed by pharmaceutical excipient selection.
Versatile Application Potential
Benefit from the adaptability of HPMCAS as a polymer carrier, microcapsule component, and for developing sophisticated sustained-release formulations.
Key Applications
Enteric Coating
This is the primary application for HPMCAS, providing a pH-dependent barrier to protect drugs in the stomach and release them in the intestine, a vital function for many medications.
Microcapsules and Microspheres
HPMCAS serves as a material for creating protective shells for active ingredients, enabling precise delivery and controlled release profiles.
Sustained-Release Formulations
The properties of HPMCAS allow for the development of drug products that release their active ingredients over an extended period, improving patient compliance and efficacy.
Polymer Carriers
As a polymer carrier, HPMCAS can enhance the solubility and bioavailability of poorly soluble drugs, contributing to more effective therapeutic outcomes.